Related Experiment Videos
[New treatments in movement disorders]
1Sección de Trastornos del Movimiento, Hospital de la Santa Creu i Sant Pau, Barcelona.
Neurologia (Barcelona, Spain)
|February 5, 2000
Summary
Recent advances in movement disorder treatments, including new therapies for dystonia and Parkinson's disease, have significantly improved patient quality of life. Experimental treatments offer future hope for neurodegenerative conditions.
Area of Science:
- Neurology
- Neuroscience
- Genetics
Context:
- Significant advancements in understanding movement disorder genetics and pathophysiology.
- Improved patient quality of life through novel therapeutic interventions.
Purpose:
- To review current treatments for Parkinson's disease, essential tremor, dystonia, and choreas.
- To highlight experimental therapies for neurodegenerative diseases.
Summary:
- Discusses new treatments like botulinum toxin for dystonia and advanced levodopa formulations for Parkinson's disease.
- Covers new surgical techniques for Parkinson's disease complications such as dyskinesias.
- Reviews current management of essential tremor and choreas.
Impact:
- Provides an overview of established and emerging treatments for movement disorders.
- Explores promising experimental therapies including neuroprotective drugs, neurotrophic factors, and neuronal implants.
- Offers renewed perspectives for neurodegenerative diseases like Huntington's chorea and Parkinson's disease.